Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: Association with pre- and posttreatment FDG-PET

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 3, 2011, Pages 772-777

  Olsen, Jeffrey R ^a   Dehdashti, Farrokh ^a,c   Siegel, Barry A ^a,c   Zighelboim, Israel ^b,c   Grigsby, Perry W ^a,b,c   Schwarz, Julie K ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; FDG-PET; FLUORODEOXYGLUCOSE; LYMPH NODE; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; POST TREATMENT; PRE-TREATMENT; PROGNOSTIC SIGNIFICANCE; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA;

ANTIGENS; BODY FLUIDS; CELLS; DIAGNOSIS; METABOLISM; POSITRON EMISSION TOMOGRAPHY;

SILVER;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; SERPINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 80053604099     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.008     Document Type: Article

References (22)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
2. Cancer Facts & Figures 2009. American Cancer Society; 2009. Accessed July 11, 2010. http://www.cancer.org/acs/groups/content/@nho/documents/document/ 500809webpdf.pdf.
3. J.M. Duk, H.W. de Bruijn, and K.H. Groenier Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations Gynecol Oncol 39 1990 186 194 (Pubitemid 20372410)
4. J.H. Hong, C.S. Tsai, and J.T. Chang The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy Int J Radiat Oncol Biol Phys 41 1998 823 830 (Pubitemid 28285960)
5. B.S. Bolger, M. Dabbas, and A. Lopes Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma Gynecol Oncol 65 1997 309 313 (Pubitemid 27216946)
6. R. Molina, X. Filella, and J.A. Lejarcegui Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer Tumour Biol 24 2003 156 164 (Pubitemid 37465053)
7. M. Takeda, N. Sakuragi, and K. Okamoto Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix Acta Obstetr Gynecol Scand 81 2002 451 457 (Pubitemid 34527152)
8. T. Ohno, Y. Nakayama, and S. Nakamoto Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix Cancer 97 2003 3114 3120 (Pubitemid 36676268)
9. G. Scambia, P. Benedetti Panici, and E. Foti Squamous cell carcinoma antigen: Prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer J Clin Oncol 12 1994 2309 2316 (Pubitemid 24346700)
10. F. Forni, G. Ferrandina, and F. Deodato Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: Evaluation of cost-effectiveness Int J Radiat Oncol Biol Phys 69 2007 1145 1149 (Pubitemid 47625847)
11. O. Micke, F.J. Prott, and U. Schafer The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer Anticancer Res 20 2000 5113 5115 (Pubitemid 32319091)
12. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 2001 3745 3749 (Pubitemid 32844787)
13. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JAMA 298 2007 2289 2295 (Pubitemid 350146219)
14. W.C. Chang, Y.C. Hung, and C.C. Lin Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels - a preliminary report Cancer Invest 22 2004 180 184 (Pubitemid 38725171)
15. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
16. E.A. Kidd, B.A. Siegel, and F. Dehdashti The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 2007 1738 1744 (Pubitemid 47557298)
17. T.R. Miller, and P.W. Grigsby Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int J Radiat Oncol Biol Phys 53 2002 353 359 (Pubitemid 34522101)
18. Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomogrophy simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. In press.
19. J.M. Duk, K.H. Groenier, and H.W. de Bruijn Pretreatment serum squamous cell carcinoma antigen: A newly identified prognostic factor in early-stage cervical carcinoma J Clin Oncol 14 1996 111 118 (Pubitemid 26020003)
20. K. Ohara, Y. Tanaka, and H. Tsunoda Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging Obstetr Gynecol 100 2002 781 787 (Pubitemid 35300038)
21. K. Sueoka, S. Nawata, and T. Nakagawa Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines Int J Oncol 27 2005 1345 1353
22. E.A. Kidd, and P.W. Grigsby Intratumoral metabolic heterogeneity of cervical cancer Clin Cancer Res 14 2008 5236 5241